Stock screener
All disclosures →
EDGAR →
BCRX
Conviction 86HealthcareScan · Tue, Sep 8, 2026BCRX$9.06-9.04%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.8M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +0.00%· 2 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price9.06
Change-9.04%
Gap-7.28%
Rel volume2.55×
Avg volume3.03M
Avg $ vol29.86M
SMA 209.87
SMA 509.73
SMA 2008.58
Price vs 50-6.89%
Price vs 200+5.57%
MA stackmixed
50/200 cross—
Supertrendup · 8.96
RSI (14)39
MACD hist-0.05
MACD crossbear · 0d
Stoch %K / %D8 / 52
ADX (14)15
+DI / −DI21 / 31
RSI divergence—
MACD divergenceBearish
ATR %+4.68%
ADR %3.94%
52w high11.11
52w low6.24
From 52w high-18.45%
Above 52w low+45.19%
New 52w highNo
SqueezeFired
Bollinger width12.35%
%B-0.16
Donchian pos5.81%
Donchian high10.68
Donchian low8.96
AVWAP (52w high)9.65
vs AVWAP high-6.15%
AVWAP (52w low)8.38
vs AVWAP low+8.14%
OBV trendFlat
Chaikin MF (20)0.15
Today vs 20d2.55×
Avg vol (14d)2.8M
Avg vol (20d)3.03M
Avg $ vol (20d)29.86M
Market cap2.32B
RS 3m (vs SPY)+14.00%
RS 6m (vs SPY)+2.91%
RS line new highNo
Trend template7/8
Technical rank37.9
1 week-6.60%
1 month-3.41%
3 months+7.47%
6 months+5.10%
1 year+9.55%
YTD+20.80%
P/E8.77
P/B-5.10
P/S91.92
P/FCF6.67
EPS1.21
Div yield—
ROE-58.08%
ROA47.30%
Debt/Eq-0.87
Current2.32
EV/EBITDA7.46
Gross margin—
Net margin—
Rev growth-4.43%
EPS growth396.87%
Price target20.44
Target upside125.61%
Analyst ratingBuy
Institutional118.12%
Ent. value2.56B
Revenue8.76M
Net income78.39M
Gross profit—
Free cash flow347.03M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out254.16M
Employees435
ListedThu, Mar 3, 1994
Free float199.32M
Float %94.6%
Short interest32.94M
Days to cover8.0d
Short volume54.9%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.30 vs $0.14
Last surprise+114.3% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank37.9 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.46
Support8.86
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling DiseaseStocktwits · Tue, Sep 8, 2026
- CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease PortfolioYahoo Finance · Tue, Sep 8, 2026
- Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs?Stocktwits · Mon, Sep 7, 2026
- Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow ItMarketbeat · Sun, Sep 6, 2026
- Dow, S&P 500, Nasdaq Futures Flip Early Gains As Iran Talk Optimism Cools: Why VCX, MU, BCRX, CMCL, DKNG Are Trending After-HoursStocktwits · Sun, Sep 6, 2026
Congress activity
Disclosed STOCK Act trades in BCRX · 2 recent
Insider activity
SEC Form 4 transactions in BCRX · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Frank Steven Director · Common Stock · 2026-08-31 | Grant | 1.29K | $12K | 2026-08-31 | 2026-09-02 |
McKee Amy E Director · Common Stock · 2026-08-31 | Grant | 644 | $6K | 2026-08-31 | 2026-09-02 |
MILANO VINCENT Director · Common Stock · 2026-08-31 | Grant | 1.16K | $11K | 2026-08-31 | 2026-09-02 |
Milne Jill C. Director · Common Stock · 2026-08-31 | Grant | 1.29K | $12K | 2026-08-31 | 2026-09-02 |
Stonehouse Jon P Director · Common Stock · 2026-08-31 | Grant | 644 | $6K | 2026-08-31 | 2026-09-02 |
Frank Steven Director · Common Stock · 2026-05-29 | Grant | 1.26K | $11K | 2026-05-29 | 2026-06-02 |
Stonehouse Jon P Director · Common Stock · 2026-05-29 | Grant | 631 | $6K | 2026-05-29 | 2026-06-02 |
Stonehouse Jon P Director · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
MILANO VINCENT Director · Common Stock · 2026-05-29 | Grant | 1.12K | $10K | 2026-05-29 | 2026-06-02 |
McKee Amy E Director · Common Stock · 2026-05-29 | Grant | 631 | $6K | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in BCRX · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.